CHELATION (EDTA) THERAPY  

Sorry, your browser doesn't support Java(tm).
This is a wonderful treatment for those who suffer with coronary artery 
disease (hardening of the arteries), circulation problems, cholesterol 
problems, heavy-metal exposure and toxicity. The primary ingredient in 
this infusion is the synthetic amino acid (a protein component) EDTA. It 
is referred to as the “chelate” a Greek term meaning “claw”. EDTA was first 
used in the mid 1900s as a means of treating lead poisoning and is still used 
today in medical centers and clinics in the U.S. and around the world for 
this purpose. However, within a short period of time from its inception as 
a treatment modality, it was observed that chest pain (angina) patients 
were experiencing and reporting alleviation of their angina. Scientists 
investigating this effect discovered that EDTA affects the plaque buildup 
in arteries. Plaque is the internal “corrosion” that commonly clogs the 
arteries. EDTA stimulates the processes by which the cellular components of 
the plaque, such as heavy metals, mucopolysaccharides, calcium, 
cholesterol, collagen, fibrin, foreign proteins, and other debris release their 
hold on the internal wall of the arteries. These particles then become a part of 
the EDTA structure and leave the bloodstream through the kidneys to 
be eliminated in the urine. Further studies revealed that the EDTA was 
clearing the body of abnormally deposited calcium from other parts of the 
body, such as in traumatized tendons, inflamed bursae, kidney stones, 
arthritic joints, and strained ligaments. I.V. EDTA does not remove calcium 
from bones and teeth; rather, EDTA chelation therapy tends to strengthen 
the bone by reactivating dormant but healthy bone-forming cells.

Chelation therapy is a mainstream treatment in most European countries 
today, although it has been suppressed by the mainstream medical powers in 
the U.S. In fact, Great Britain requires patients first undergo a series of 
chelation treatments for coronary artery disease before they can be 
considered operative candidates for bypass surgery.

A NEW THEORETICAL MECHANISM OF ACTION OF EDTA CHELATION THERAPY

NIH To Initiate a $30M Chelation Study 
How will the NIH study be conducted? 

Results Of Coronary Artery Bypass Surgery on Survival:

Bypass Surgeon Endorses EDTA Chelation Therapy
WITH A CASE REPORT 

Case from the Center
Coronary Artery Occlusion, Chelation and Cholesterol 
in a 49-year Old Pilot

Linus Pauling Endorses EDTA Chelation Therapy

CHELATION CRITICS PUBLISH DECEPTIVE DATA

Does EDTA chelation therapy have side effects? 

Effect of EDTA Chelation Therapy Plus
Multi-vitamin/Trace Mineral Supplementation Upon Vascular Dynamics: Ankle/Brachial Doppler Systolic Blood Pressure Ratio

If EDTA Chelation Therapy is so Good, 
Why Is It Not More Widely Accepted?

Invasive Revascularization does not Improve Mortality After Heart Attack

ORAL CHELATION WITH EDTA IS INEFFECTIVE AND DANGEROUS